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Congenital central hypoventilation syndrome (CCHS) causes predominantly sleep apnoea and is one of a 
growing number of inherited disorders characterised by autonomic nervous system dysfunction/dysregula-
tion (ANSD). In association with Hirschsprung’s disease (HSCR), it presents as Haddad’s syndrome. We re-
port a case of Haddad’s syndrome complicated by sinus node dysfunction.
C ongenital central hypoventilation syndrome (CCHS) is a very rare disorder characterised by inade-
quate ventilation during sleep.1 It is an in-
herited autosomal dominant disease char-
acterised by a PHOX2B mutation.2 Rec-
ognised as part of the autonomic nervous 
system dysfunction/dysregulation (ANSD) 
group of disorders, CCHS is usually as-
sociated with neural crest tumours and/
or enteric nervous system abnormalities, 
such as Hirschsprung’s disease (HSCR), 
the latter known also as Haddad’s syn-
drome.3 Patients with CCHS have a high 
frequency of arrhythmias and are at in-
creased risk of sudden death.1,4
Case presentation
A 3-year-old boy with a history of recur-
rent apnoea episodes during his neona-
tal period is presented. At that time he 
was hospitalised, intubated and treated 
in the neonatal ICU. Given the frequen-
cy and severity of the episodes and his in-
ability to be extubated he underwent tra-
cheostomy and permanent mobile me-
chanical ventilation support was institut-
ed. Genetic molecular tests were positive 
for PHOX2B gene mutation (20/27 geno-
type) and the diagnosis of CCHS was es-
tablished. The fact that he was also found 
to have Hirschsprung’s disease, for which 
he underwent a two stage-repair, classi-
fies the patient in the Haddad syndrome 
group.
During recent hospitalisation for a vi-
ral gastrointestinal tract infection the pa-
tient suffered an episode of cardiac arrest 
in the form of asystole, from which he was 
successfully resuscitated. Holter record-
ings following this incident revealed re-
peat episodes of sinus pauses more than 
3 s in duration during sleep, with one 
of them reaching 6 s, while others ap-
peared even when he was awake and dur-
ing daytime (Figure 1). Consequently, a 
transvenous permanent VVI pacemaker 
(Adapta®, Medtronic Inc., Minneapolis, 
USA) was implanted under general an-
aesthesia, utilising a 52 cm screw-in type 
lead (CapSureFix Novus™, Model 5076, 
Medtronic Minneapolis, USA) via the left 
subclavian vein, the length of which was 
calculated according to his height, as pre-
viously described (Figure 2).5 Measure-
ments were excellent and the pacemaker 
is set to operate at 60 bpm.
Discussion
CCHS has also been known as Ondine’s 
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curse. Ondine (or “Undine”), a mythological figure, 
was a water nymph or sprite with an unfaithful mortal 
lover who swore to her that his “every waking breath 
would be a testimony of his love”. Upon witnessing 
his adultery, she cursed that if he should fall asleep, 
he would forget to breathe.6
CCHS is inherited in an autosomal dominant 
manner and a PHOX2B mutation is required to con-
firm the diagnosis. The syndrome is present at birth, 
yet diagnosis may be delayed because of the diversity 
in the severity of its manifestations. Identification of 
the gene related to this disease has been followed by 
an increasing interest in genotype–phenotype corre-
lation for its different manifestations, including car-
diovascular abnormalities.7,8 CCHS is associated with 
neural crest tumours (neuroblastomas) and/or enter-
ic nervous system abnormalities owing to defective 
migration of neural crest cells.3,9,10 Currently, near-
ly 1000 individuals worldwide have PHOX2B muta-
tion-confirmed CCHS, although some feel that this 
number is most likely underestimated.2,7 About 15-
20% of patients with CCHS are known also to have 
Hirschsprung’s disease (aganglionic megacolon), an 
extremely rare combination (less than 1 in 1,000,000 
live births) termed Haddad syndrome by some.3,7,11 
Interestingly, inconclusive current evidence points to 
PHOX2B gene involvement in Hirschsprung’s dis-
ease.12 In addition, Haddad syndrome has been re-
ported in association with other genetic disorders 
such as Down syndrome.13
CCHS is characterised in general by adequate 
ventilation while the patient is alert and hypoven-
tilation, with typically normal respiratory rates and 
diminished tidal volume, during sleep. More se-
verely affected children hypoventilate both awake 
and asleep. In particular while asleep, children with 
CCHS experience progressive hypercapnea and hy-
poxaemia, due to absent or negligible ventilatory sen-
sitivity to these factors.2,4,14 Nevertheless, their ven-
tilation is more “normal” in rapid eye movement 
sleep.15 During exercise these children may be at risk 
for hypercarbia and hypoxaemia, because although 
they maintain conscious control of breathing they 
lack perception of dyspnoea.4,16 In general, patients 
exhibit sustained abnormalities in control of breath-
ing and continue to require long-term ventilatory sup-
port, with several of them, however, entering early 
adulthood. On occasion, these patients will demon-
strate apnoeic pauses after discontinuation of me-
chanical ventilation and before initiation of spontane-
ous breathing.17
Children with CCHS exhibit an increased fre-
quency of arrhythmia, primarily sinus bradycardia 
and transient asystole.4 It has been postulated that 
inadequate central control of ventilation with de-
creased sensitivity to hypoxia and hypercapnia may 
be associated with the cardiac rhythm disturbances 
observed.14 Patients with CCHS display several as-
Figure 2. Chest X-ray showing pacemaker implantation. The long 
pacing lead allows for the child’s growth.
Figure 1. ECG strip showing a 6-s sinus pause.
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sociated cardiovascular symptoms reflecting ANSD, 
and the cardiovascular profile suggests vagal dys-
function.18 Moreover, recent research has revealed 
evidence of PHOX2B gene involvement in sudden 
infant death syndrome.19 Nevertheless, studies con-
firm a disturbance of cardiac autonomic regulation in 
CCHS, indicate that PHOX2B genotype is related to 
the severity of dysregulation, and predict the need for 
a cardiac pacemaker, thus offering the potential to 
avert sudden death.1
Atrial pacing has been shown to be beneficial in 
reducing the number of apnoea episodes. In particu-
lar, there is evidence to show that reducing the vari-
ations in heart rate, caused in part by changes in au-
tonomic tone, markedly reduces the number of epi-
sodes of sleep apnoea. Atrial pacing counteracts sus-
tained increases in vagal tone by maintaining sympa-
thetic activity.20
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